Dietary Fatty Acid Composition and Obesity-related Metabolic Abnormalities

Sponsor
University of Michigan (Other)
Overall Status
Completed
CT.gov ID
NCT01451970
Collaborator
Robert C. Atkins Foundation (Other)
40
1
2
40.4
1

Study Details

Study Description

Brief Summary

Individuals have a significant capacity to adapt to different environments by changing their core metabolic pathways. This adaptation is especially important in regards to diet. Epidemiological research over the last several decades have shown that diets high in saturated fats have a greater ability to cause insulin resistance and the 'metabolic syndrome' while diets low in saturated fats (or a so called 'Mediterranean Diet), reduces the risk for cardiovascular disease. In humans, experimental diets high in unsaturated fats, as compared to high carbohydrate or high saturated fat diets, result in increased insulin sensitivity and improved lipid profiles.

In this application, the investigators propose to systematically assess the effects of two diets enriched in either saturated or unsaturated fatty acids and determine the cellular and molecular mechanisms of the apparent increase in insulin sensitivity. The investigators hypothesize that individuals will 'adapt' to the different diets and the investigators will be able to generate predictive alterations in gene expression and metabolites that underlie the alterations in metabolism. In parallel, the investigators will test the ability of these different diets to affect the release of gastrointestinal hormones that may be critical to modulation of appetite.

Condition or Disease Intervention/Treatment Phase
  • Other: High Fat Diet
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Assessing the Effects of Two Diets Enriched in Either Saturated or Unsaturated Fatty Acids to Determine the Cellular and Molecular Mechanisms in Insulin Sensitivity
Study Start Date :
Aug 1, 2007
Actual Primary Completion Date :
Dec 12, 2010
Actual Study Completion Date :
Dec 12, 2010

Arms and Interventions

Arm Intervention/Treatment
Other: High Monounsaturated Fat Diet

Subjects will adhere to their specific diet for four weeks. The diet will be a weight-maintaining diet, and the target nutrient composition for diets will be 55% carbohydrate, 30% fat, 15% protein. For the monounsaturated fat treatment (M diet) approximately 10% of all lipids ingested will be saturated.

Other: High Fat Diet
Subjects will adhere to their specific diet for four weeks. For both diet treatments, the diet will be a weight-maintaining diet, and the target nutrient composition for diets will be 55% carbohydrate, 30% fat, 15% protein. For the monounsaturated fat treatment (M diet) approximately 10% of all lipids ingested will be saturated. For the saturated fat treatment (S diet) approximately 40% of all lipids ingested will be saturated.

Other: High Saturated Fat Diet

Subjects will adhere to their specific diet for four weeks. The diet will be a weight-maintaining diet, and the target nutrient composition for diets will be 55% carbohydrate, 30% fat, 15% protein. For the saturated fat treatment (S diet) approximately 40% of all lipids ingested will be saturated.

Other: High Fat Diet
Subjects will adhere to their specific diet for four weeks. For both diet treatments, the diet will be a weight-maintaining diet, and the target nutrient composition for diets will be 55% carbohydrate, 30% fat, 15% protein. For the monounsaturated fat treatment (M diet) approximately 10% of all lipids ingested will be saturated. For the saturated fat treatment (S diet) approximately 40% of all lipids ingested will be saturated.

Outcome Measures

Primary Outcome Measures

  1. Insulin Sensitivity [2-3 hours]

    A hyperinsulinemic-euglycemic clamp will be used to assess insulin sensitivity.

Secondary Outcome Measures

  1. Resting Metabolic Rate [20-30 min]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 45 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Premenopausal females with BMI range of 25-32 kg/m2
Exclusion Criteria:
  • Evidence of metabolic or cardiovascular disease, Fasting plasma glucose concentration

125mg/dl, Abnormal EKG, Hyperlipidemia (plasma triglyceride concentration > 150mg/dl), Pregnancy, Hematocrit <34%

Contacts and Locations

Locations

Site City State Country Postal Code
1 Michigan Clincal Research Unit Ann Arbor Michigan United States 48109

Sponsors and Collaborators

  • University of Michigan
  • Robert C. Atkins Foundation

Investigators

  • Principal Investigator: Jeffrey F Horowitz, Ph.D., University of Michigan

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jeffrey F Horowitz, Associate Professor, Movement Science, School of Kinesiology, University of Michigan
ClinicalTrials.gov Identifier:
NCT01451970
Other Study ID Numbers:
  • N009310
First Posted:
Oct 14, 2011
Last Update Posted:
Mar 21, 2022
Last Verified:
Mar 1, 2022
Keywords provided by Jeffrey F Horowitz, Associate Professor, Movement Science, School of Kinesiology, University of Michigan
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 21, 2022